Gish Biomedical's Vision cleared for marketing:
This article was originally published in Clinica
Gish Biomedical's Vision oxygenator, a component of its cardiovascular bypass system that replaces lung function during surgery, has been cleared by the FDA for marketing in the US. The device enables exchange of oxygen and carbon dioxide, while regulating the patient's blood temperature. Gish Biomedical, based in Irvine, California, says that it will release the device early next year.